Abstract The World Health Organization (WHO), the International Academy of Cytology, and
the International Agency for Research on Cancer, with expert contributors from around the …

Background Health care improvement efforts should be aligned in order to make a
meaningful impact on health systems. Appropriate care delivery could be a unifying goal to …

Background and Aims EUS-guided FNA (EUS-FNA) is the criterion standard for the
diagnosis of solid pancreatic lesions. Several studies assessed the role of repeat EUS-FNA …

Simple Summary Histological sampling is the cornerstone of diagnosis for patients with solid
pancreatic lesions. Endoscopic ultrasound guided fine needle biopsy (EUS FNB) is the most …

Abstract (200 words) BACKGROUND Neoadjuvant treatment for pancreatic ductal
adenocarcinoma (PDAC) has increased, necessitating histopathologic confirmation of …

The effectiveness of neoadjuvant therapy (NAT) remains controversial in the treatment of
pancreatic cancer (PC). Therefore, this meta-analysis aimed to investigate the clinical …

These recommendations refer to the current management in pancreatic ductal
adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely …

Background Biopsy of suspected pancreatic cancer (PDAC) in surgical candidates is
informative however not always necessary. Biopsies impact treatment options as histological …

Background Pancreatic ductal adenocarcinoma (PDAC) is highly malignant with a very poor
prognosis due to its silent development and metastatic profile with a 5-year survival rate …

Methods Of 5,894 patients subjected to EUS-FNA/B, 237 (4.0%) with an initially inconclusive
diagnosis of SPLs were retrospectively enrolled from five tertiary medical centers between …